Anaergia AI Stock Analysis
Want to see TSE:ANRG full AI Analyst Report?
Anaergia (ANRG) AI Stock Analysis
Anaergia
(TSX:ANRG)
The score is primarily held back by weak financial quality—negative equity and negative free cash flow despite improving revenue and positive net income. Technicals also remain bearish with the stock below major moving averages and negative MACD. Offsetting factors include a constructive earnings call with record backlog, continued positive adjusted EBITDA, and balance-sheet actions (divestitures and expanded credit capacity), while valuation appears moderate based on the provided P/E.
Anaergia (ANRG) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 369.04M
- Dividend Yield
- ―
- Average Volume (3M)
- 136.31K
- Price to Earnings (P/E)
- 28.0
- Beta (1Y)
- 1.04
- Revenue Growth
- 80.79%
- EPS Growth
- ―
- Country
- Canada
- Employees
- 285
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Waste Management
Anaergia Business Overview & Revenue Model
Company Description
Anaergia Inc., together with its subsidiaries, provides solutions for the generation of renewable energy and conversion of waste to resources in Italy, North America, Europe, the Middle East and Africa, and the Asia Pacific. It operates through three...
How the Company Makes Money
Anaergia primarily makes money through (1) project development and delivery and (2) ongoing services tied to operating waste-to-energy/waste-to-resources facilities. 1) Project/EPC and technology-related revenue - Anaergia generates revenue by design...
Anaergia Earnings Call Summary
The call was strongly positive, with substantial revenue growth, a record $303.1 million backlog, positive adjusted EBITDA for the fifth consecutive quarter, a return to net income, portfolio simplification, debt reduction, expanded credit capacity, and major new awards in Hungary and Australia. The main challenges were year-over-year gross margin compression, higher quarterly SG&A, the prior underperformance of divested facilities, the gradual SoCal capacity ramp, and the need to convert backlog into earnings and cash flow.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said it is “more confident than ever” that capital sales backlog will be “much higher” than today, with “a few more” releases in the upcoming weeks; CapEx “will go back to normal”; previously announced capital sale contracts are “well into execution,” large projects in Italy and North America are “proceeding normal course,” and “we expect that trend to continue.” SoCal Biomethane is expected to improve “towards full capacity over the coming quarters,” with the company “approaching the nameplate” “over the coming quarters into next year.” Management does not expect “a material change on SG&A” as more work is secured, with additional resources added “as needed” and project costs “accretive to bottom line.”
Anaergia Financial Statement Overview
Summary
Revenue growth has improved (TTM +15%) and net margin is positive (~6.4%), but operating profitability remains weak (EBIT still negative). The balance sheet is a major risk with negative stockholders’ equity (-$49.0M), and cash generation is the weakest link with negative free cash flow (-$5.6M) and poor cash conversion versus net income (FCF to NI -3.17).
Income Statement
46NeutralBalance Sheet
28NegativeCash Flow
22Negative| Breakdown | TTM | Dec 2025 | Mar 2025 | Jun 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 242.21M | 180.20M | 111.65M | 147.22M | 162.85M | 129.87M |
| Gross Profit | 47.31M | 40.01M | 25.63M | 14.60M | 28.60M | 31.63M |
| EBITDA | 7.92M | -7.66M | -38.37M | -185.49M | -53.59M | -15.52M |
| Net Income | 15.48M | 6.96M | -42.89M | -182.60M | -68.57M | -17.21M |
Balance Sheet | ||||||
| Total Assets | 260.90M | 237.94M | 233.33M | 278.67M | 935.11M | 703.91M |
| Cash, Cash Equivalents and Short-Term Investments | 25.66M | 43.45M | 30.22M | 22.11M | 55.38M | 79.32M |
| Total Debt | 74.57M | 64.69M | 71.71M | 70.89M | 377.65M | 221.50M |
| Total Liabilities | 205.13M | 182.41M | 180.12M | 205.08M | 592.97M | 367.30M |
| Stockholders Equity | -48.97M | -46.28M | -57.65M | -55.38M | 208.84M | 218.02M |
Cash Flow | ||||||
| Free Cash Flow | -5.58M | 3.26M | -41.01M | -130.87M | -152.97M | -127.54M |
| Operating Cash Flow | 1.76M | 9.88M | -30.23M | -66.76M | -30.56M | -38.95M |
| Investing Cash Flow | -26.52M | -22.89M | 10.90M | -27.80M | -192.50M | -149.62M |
| Financing Cash Flow | 16.05M | 5.21M | 32.52M | 64.76M | 198.13M | 239.55M |
Anaergia Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ANRG, the sentiment is Neutral. The current price of 2.14 is above the 20-day moving average (MA) of 1.87, below the 50-day MA of 2.20, and below the 200-day MA of 2.49, indicating a neutral trend. The MACD of -0.09 indicates Negative momentum. The RSI at 59.26 is Neutral, neither overbought nor oversold. The STOCH value of 72.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:ANRG.
Anaergia Peers Comparison
Overall Rating
TSE:ANRG49Neutral
TSE:YES40Underperform
TSE:ROOF38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| 49Neutral | CAD 318.95M | 28.01 | -25.27% | ― | 80.79% | ― | |
| 40Underperform | CAD 26.45M | -90.00 | -6.70% | ― | 11.30% | 97.22% | |
| 38Underperform | CAD 20.70M | -1.30 | 152.16% | ― | 6.95% | -13.65% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:ANRG | Anaergia, Inc. | 2.14 | -0.09 | -4.04% | |
| TSE:YES | CHAR Technologies | 0.18 | -0.02 | -10.00% | |
| TSE:VTX | Vertex Resource Group Ltd. | 0.25 | 0.06 | 31.58% | |
| TSE:ROOF | Northstar Clean Technologies, Inc. | 0.14 | -0.16 | -54.10% |
Anaergia Corporate Events
Anaergia Wins C$34 Million Hungarian Biomethane Contract
PositiveAnaergia is a global technology and project delivery company that converts organic waste into renewable natural gas, fertilizer and clean water. Its integrated waste-to-value solutions serve municipalities, utilities, industrial customers and project...
Anaergia Schedules Third-Quarter 2026 Results Release and Webcast
NeutralAnaergia plans to publish third-quarter 2026 financial results after market close on November 11 and host an investor webcast the following morning. Senior executives will discuss the period ended September 30, giving shareholders and other stakehold...
Anaergia Sheds Non-Core Bioenergy Assets to Cut Debt and Refocus on Profitable Growth
PositiveAnaergia has sold its Charlotte Bioenergy Facility in North Carolina and its interests in the Rhode Island Bioenergy Facility, advancing a strategic shift toward more profitable assets and core markets. The company, which specializes in transforming...
Anaergia Strikes C$36 Million Waste‑to‑Energy Deal with Hungary’s TisVet
PositiveAnaergia, through its Italian subsidiary Anaergia Srl, has signed a C$36 million technology and engineering agreement with Hungarian poultry producer TisVet Kft for a major agricultural‑waste‑to‑energy project in Hungary. The new anaerobic digestion...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
